Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin F Fromm

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Clinical Pharmacokinetics|August 24, 2007
Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated effluxSvitlana Igel, Siegfried Drescher, Thomas Mürdter, et al.
The Journal of Biological Chemistry|April 10, 2002
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestineOliver Burk, Heike Tegude, Ina Koch, et al.
Clinical Pharmacology and Therapeutics|March 22, 2002
Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transportersHartmut Glaeser, Siegfried Drescher, Heiko van der Kuip, et al.
JCO Oncology Practice|June 7, 2024
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation CenterLisa Cuba, Pauline Dürr, Katja Gessner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2018
Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohortRenke Maas, Maren Mieth, Stephanie I Titze, et al.
Clinical Pharmacology and Therapeutics|December 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World DataMichael I Sponfeldner, Pauline Dürr, Phyllis Lensker, et al.
Pharmacological Research|September 29, 2023
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validationAnne T Nies, Jörg König, Patrick Leuthold, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Clinical Pharmacokinetics|November 22, 2007
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studiesSonja Eberl, Bertold Renner, Antje Neubert, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Clinical Pharmacokinetics|August 24, 2007
Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated effluxSvitlana Igel, Siegfried Drescher, Thomas Mürdter, et al.
The Journal of Biological Chemistry|April 10, 2002
Molecular mechanisms of polymorphic CYP3A7 expression in adult human liver and intestineOliver Burk, Heike Tegude, Ina Koch, et al.
Clinical Pharmacology and Therapeutics|March 22, 2002
Shed human enterocytes as a tool for the study of expression and function of intestinal drug-metabolizing enzymes and transportersHartmut Glaeser, Siegfried Drescher, Heiko van der Kuip, et al.
JCO Oncology Practice|June 7, 2024
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation CenterLisa Cuba, Pauline Dürr, Katja Gessner, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 27, 2018
Drugs linked to plasma homoarginine in chronic kidney disease patients-a cross-sectional analysis of the German Chronic Kidney Disease cohortRenke Maas, Maren Mieth, Stephanie I Titze, et al.
Clinical Pharmacology and Therapeutics|December 22, 2025
Extent and Incidence of Pseudo-Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real-World DataMichael I Sponfeldner, Pauline Dürr, Phyllis Lensker, et al.
Pharmacological Research|September 29, 2023
Novel drug transporter substrates identification: An innovative approach based on metabolomic profiling, in silico ligand screening and biological validationAnne T Nies, Jörg König, Patrick Leuthold, et al.
Gastroenterology|January 4, 2003
Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitisMatthias Schwab, Elke Schaeffeler, Claudia Marx, et al.
Clinical Pharmacokinetics|June 7, 2020
Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and CimetidineSabrina T Wiebe, Thomas Giessmann, Kathrin Hohl, et al.
Clinical Pharmacokinetics|November 22, 2007
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studiesSonja Eberl, Bertold Renner, Antje Neubert, et al.
Pageof 19